J. Loutit

发表

Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

T. Fleming, J. Powers, A. Torres, 2019, The Journal of infectious diseases.

Aerosol antibiotics: considerations in pharmacological and clinical evaluation.

D. C. Griffith, J. Loutit, M. Dudley, 2008, Current opinion in biotechnology.

Potency of Meropenem-Vaborbactam in Lung Surfactant

J. Loutit, M. Dudley, O. Lomovskaya, 2017, Antimicrobial Agents and Chemotherapy.

Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects

D. C. Griffith, J. Loutit, E. Wenzler, 2015, Antimicrobial Agents and Chemotherapy.

Meropenem-RPX 7009 Concentrations in Plasma , Epithelial Lining Fluid , and Alveolar Macrophages of Healthy Adult Subjects

D. C. Griffith, J. Loutit, E. Wenzler, 2015 .

Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cells

S. Falkow, L. Tompkins, J. Loutit, 1995, Infection and immunity.

Bartonella infections.

J. Loutit, 1997, Current clinical topics in infectious diseases.

Lemierre's syndrome.

J. Loutit, M. Genovese, F. López, 1997, Southern medical journal (Birmingham, Ala. Print).

Pharmacokinetic-Pharmacodynamic Relationships Describing the Efficacy of Oritavancin in Patients with Staphylococcus aureus Bacteremia

J. Loutit, S. Porter, S. Bhavnani, 2006, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Oritavancin in Plasma and Skin Blister Fluid following Administration of a 200-Milligram Dose for 3 Days or a Single 800-Milligram Dose

J. Loutit, D. Nicolau, S. Porter, 2005, Antimicrobial Agents and Chemotherapy.

Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases.

M. Totrov, K. R. Reddy, J. Loutit, 2015, Journal of medicinal chemistry.

Meropenem-Vaborbactam vs. Piperacillin-Tazobactam in TANGO I (a Phase 3 Randomized, Double-blind Trial): Outcomes by Baseline MIC in Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis

T. File, A. Shorr, T. Walsh, 2017 .

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

P. Peduzzi, K. Schmader, M. Irwin, 2005, The New England journal of medicine.

The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens.

S Falkow, D. Relman, T. Schmidt, 1990, The New England journal of medicine.

Meropenem-Vaborbactam vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection

R. Wunderink, K. Kaye, J. Solomkin, 2017 .

Meropenem-Vaborbactam Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses as Support for Dose Selection in Patients with Normal Renal Function and Varying Degrees of Renal Impairment

J. Loutit, M. Dudley, S. Bhavnani, 2017 .

Cerebral sparganosis: case report and review.

G. Steinberg, J. Almenoff, J. Loutit, 1991, Reviews of infectious diseases.

Pneumocephalus due to invasive fungal sinusitis.

G. Engel, J. Loutit, W. Fearon, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Outcomes of Serious Infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) in TANGO II, a Phase 3, Randomized, Multi-National, Open-Label Trial of Meropenem-Vaborbactam (M-V) Vs. Best Available Therapy (BAT)

K. Kaye, A. Mathers, J. Loutit, 2017 .

A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program

J. Loutit, M. Dudley, G. Moeck, 2018, Open forum infectious diseases.

Prosthetic valve endocarditis due to Legionella pneumophila.

J. Schapiro, J. Loutit, T. T. Chen, 1996, The Journal of cardiovascular surgery.